Today, Alexandros Sklavounos, CEO of Sci-Bots from Toronto, Canada, visited optoseeker to engage in in-depth discussions on the latest advancements in digital microfluidic technologies. This visit marks a significant step toward deepening collaboration between the two companies in the future development and production of digital microfluidic products.
Sci-Bots’ core technologies are derived from the research of Professor Aaron Wheeler at the University of Toronto, a global leader in digital microfluidics and Editor-in-Chief of the prestigious journal Lab on a Chip. Sci-Bots is dedicated to developing world-class digital microfluidic systems and accessories, with innovations that have become essential tools in biotechnology, pharmaceutical R&D, and diagnostic testing.
optoseeker is committed to delivering more efficient and precise technological solutions for the digital microfluidics research community. The digital microfluidic systems and accessories developed by optoseeker feature ultra-high precision and a highly integrated design, enabling picoliter-scale droplet manipulation and analysis within compact volumes—redefining the boundaries of what is scientifically possible.
This face-to-face exchange with Alexandros Sklavounos provided Sci-Bots with deeper insights into optoseeker’s cutting-edge digital microfluidic technologies and their applications in drug screening, biomedical research, chemical analysis, and biological sample processing. Alexandros Sklavounos expressed high praise for the innovation demonstrated by optoseeker, recognizing China’s growing leadership in digital microfluidic technology.
DropletBot® Digital Microfluidic Platform
Our goal is not only to remain at the forefront of technological innovation, but also to promote the global adoption of digital microfluidics, accelerating progress in scientific research across the field. In partnership with Sci-Bots, optoseeker will continue to expand its global influence in digital microfluidics and drive technological transformation in biomedicine.
